- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The cost-effectiveness of risk-stratified breast cancer screening in the UK ; volume:129 ; number:11 ; day:17 ; month:10 ; year:2023 ; pages:1801-1809 ; date:11.2023
British journal of cancer ; 129, Heft 11 (17.10.2023), 1801-1809, 11.2023
- Creator
-
Hill, Harry
Kearns, Ben
Pashayan, Nora
Roadevin, Cristina
Sasieni, Peter
Offman, Judith
Duffy, Stephen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-023-02461-1
- URN
-
urn:nbn:de:101:1-2024021308580756662326
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.0012, 6:39 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hill, Harry
- Kearns, Ben
- Pashayan, Nora
- Roadevin, Cristina
- Sasieni, Peter
- Offman, Judith
- Duffy, Stephen
- SpringerLink (Online service)
Other Objects (12)
The cost-effectiveness of unilateral cochlear implants in UK adults
Evaluating the cost-effectiveness of polygenic risk score-stratified screening for abdominal aortic aneurysm
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
The probability of cost-effectiveness
Modelling the cost-effectiveness of pay-for-performance in primary care in the UK
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
The clinical and cost-effectiveness of stratified care for patients with sciatica: the SCOPiC randomised controlled trial protocol (ISRCTN75449581)
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
How best to handle the evidence in a cost-effectiveness analysis of TAVI in the UK
Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
The cost-effectiveness of exercise referral schemes
The cost-effectiveness of unilateral cochlear implants in UK adults
Evaluating the cost-effectiveness of polygenic risk score-stratified screening for abdominal aortic aneurysm
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
The probability of cost-effectiveness
Modelling the cost-effectiveness of pay-for-performance in primary care in the UK
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
The clinical and cost-effectiveness of stratified care for patients with sciatica: the SCOPiC randomised controlled trial protocol (ISRCTN75449581)
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
How best to handle the evidence in a cost-effectiveness analysis of TAVI in the UK
Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
The cost-effectiveness of exercise referral schemes
The cost-effectiveness of unilateral cochlear implants in UK adults
Evaluating the cost-effectiveness of polygenic risk score-stratified screening for abdominal aortic aneurysm
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
The probability of cost-effectiveness
Modelling the cost-effectiveness of pay-for-performance in primary care in the UK
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
The clinical and cost-effectiveness of stratified care for patients with sciatica: the SCOPiC randomised controlled trial protocol (ISRCTN75449581)
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
How best to handle the evidence in a cost-effectiveness analysis of TAVI in the UK
Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS